Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-16

Clinical Trial Update: Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity. [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial from Yale examined whether liraglutide modulates neural responses to high-fructose corn syrup in individuals with obesity; the study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Yale University | Conditions: Obesity, Childhood, Neural Development | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2024-07-16